- Home
- COKE vs PEN Comparison
COKE vs PEN Comparison
Compare COKE & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COKE | PEN |
|---|---|---|
| Founded | 1902 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 13.2B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | COKE | PEN |
|---|---|---|
| Price | $184.58 | $328.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $357.33 |
| AVG Volume (30 Days) | 453.3K | ★ 529.1K |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | 156.81 | ★ 1155.56 |
| EPS | 1.21 | ★ 4.52 |
| Revenue | ★ $7,228,055,000.00 | $1,403,665,000.00 |
| Revenue This Year | N/A | $14.27 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | $149.56 | ★ $74.15 |
| Revenue Growth | 4.76 | ★ 17.50 |
| 52 Week Low | $105.21 | $221.26 |
| 52 Week High | $1,433.97 | $362.41 |
Technical Indicators
Market Signals| Indicator | COKE | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 31.56 |
| Support Level | $110.61 | $302.19 |
| Resistance Level | $209.24 | $338.99 |
| Average True Range (ATR) | 7.37 | 2.25 |
| MACD | -4.84 | -0.62 |
| Stochastic Oscillator | 18.99 | 14.31 |
Price Performance
Historical ComparisonAbout COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other and . Key revenue is generated from Nonalcoholic Beverages.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.